| LP18610-3 | Enflurane | COMPONENT | 3 |
| LP186100-6 | Influenza virus A and B Ag panel | COMPONENT | 1 |
| LP186102-2 | Cytomegalovirus DNA panel | COMPONENT | 1 |
| LP186105-5 | During the past 2 weeks, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health | COMPONENT | 1 |
| LP186106-3 | During the past 2 weeks, has your physical and emotional health limited your social activities with family, friends, neighbors or groups | COMPONENT | 1 |
| LP186107-1 | During the past 2 weeks, how much bodily pain have you generally had | COMPONENT | 1 |
| LP186108-9 | How would you rate your overall health now compared to 2 weeks ago | COMPONENT | 1 |
| LP186109-7 | During the past 2 weeks, how would you rate your health in general | COMPONENT | 1 |
| LP18611-1 | Methoxyflurane | COMPONENT | 1 |
| LP186110-5 | During the past 2 weeks, was someone available to help you if you needed and wanted help | COMPONENT | 1 |
| LP186111-3 | How have things been going for you during the past 2 weeks | COMPONENT | 1 |
| LP186112-1 | Simplified Disease Activity Index | METHOD | 2 |
| LP186113-9 | Clinical Disease Activity Index | METHOD | 3 |
| LP186116-2 | Do you sometimes drink alcoholic beverages | COMPONENT | 1 |
| LP186117-0 | How often have you had four or more drinks in one day during the past year | COMPONENT | 1 |
| LP186118-8 | Number of falls in the past 12 months | COMPONENT | 1 |
| LP18612-9 | Methylenedioxymethamphetamine | COMPONENT | 24 |
| LP186120-4 | Platelet mapping (function) panel | COMPONENT | 1 |
| LP186126-1 | B cells+monocytes | SYSTEM | 1 |
| LP186127-9 | AXIN2 gene deletion+duplication and | COMPONENT | |
| LP186128-7 | AXIN2 gene deletion+duplication and full mutation analysis | COMPONENT | 1 |
| LP186129-5 | Dartmouth Cooperative Functional Status Test (COOP) set | CLASS | |
| LP18613-7 | Butyl acetate | COMPONENT | 1 |
| LP186131-1 | Patient Activity Scale (PAS) set | CLASS | |
| LP186132-9 | Patient Activity Scale II (PASII) set | CLASS | |
| LP186133-7 | Dartmouth COOP Functional Assessment Charts - 2 weeks | COMPONENT | 1 |
| LP186134-5 | Dartmouth COOP Functional Assessment Charts - 4 weeks | COMPONENT | 1 |
| LP186135-2 | COOP | METHOD | 10 |
| LP186136-0 | Asthma Control Test | METHOD | 7 |
| LP186137-8 | Electronic Health Record (EHR) Implementation Stage | COMPONENT | 1 |
| LP186138-6 | Electronic Health Record (EHR) Implementation Stage panel | COMPONENT | 1 |
| LP186139-4 | 14-3-3 eta Ag | COMPONENT | 1 |
| LP18614-5 | Sec-butyl acetate | COMPONENT | 1 |
| LP186141-0 | HEXB gene | COMPONENT | |
| LP186142-8 | IDS gene | COMPONENT | |
| LP186143-6 | Guidance for percutaneous fluid aspiration | COMPONENT | 52 |
| LP186144-4 | Advance directives panel | COMPONENT | 2 |
| LP186145-1 | ADVault | METHOD | 1 |
| LP186146-9 | ADVault survey | CLASS | |
| LP186147-7 | ADVault survey set | CLASS | |
| LP186148-5 | Goals, preferences, and priorities for medical treatment | COMPONENT | 1 |
| LP186149-3 | Allowance to change advance directive preferences in the future regardless of mental state | COMPONENT | 1 |
| LP18615-2 | Tert-butyl acetate | COMPONENT | 1 |
| LP186150-1 | Decision to inform doctors and nurses about the role religion, faith, culture, or spirituality play in my life | COMPONENT | 1 |
| LP186151-9 | Preference on consulting a supportive and palliative care team to help treat physical, emotional, and spiritual discomfort and support family | COMPONENT | 1 |
| LP186152-7 | Information to tell doctors if my health deteriorates due to a terminal illness and I am unable to interact meaningfully with family, friends, or surroundings | COMPONENT | 1 |
| LP186153-5 | Information to tell doctors if I have a severe, irreversible brain injury or illness and can't dress, feed, or bathe myself, or communicate my medical wishes, but can be kept alive | COMPONENT | 1 |
| LP186154-3 | Thoughts on cardiopulmonary resuscitation (CPR) | COMPONENT | 1 |
| LP186155-0 | Thoughts on organ and tissue donations | COMPONENT | 1 |
| LP186156-8 | Preferred location to spend final days if possible to choose | COMPONENT | 1 |